Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anulex Technologies, a developer and marketer of soft tissue repair products, has appointed Richard Lunsford as its new president and CEO. The company also appointed him to its board of directors.
Subscribe to our email newsletter
Michael McCormick, the previous CEO has resigned to pursue other interests, the company said.
Most recently, Mr Lunsford served as senior vice president and president of US commercial operations at ev3, where he led the commercial operations for ev3’s domestic business. Previous to ev3, Mr Lunsford was president and CEO of Acorn Cardiovascular.
Dave Stassen, Anulex’s board member, said: “We are delighted by the addition of Rich to the Anulex team. Rich has a proven track record in the medical device industry and brings demonstrated entrepreneurial leadership to Anulex as we continue our commercial rollout.”